WNY Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

WNY Asset Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Buy	+14,710	New	+$246K	0.02%	226
2025 Q3	$399K	Buy	25,704 +749	+3%	+$10.3K	0.04%	163
2025 Q2	$320K	Buy	24,955 +821	+3%	+$10.1K	0.04%	174
2025 Q1	$306K	Buy	24,134 +2,988	+14%	+$40.5K	0.04%	180
2024 Q4	$277K	Hold	21,146	–	–	0.03%	182
2024 Q3	$319K	Buy	+21,146	New	+$320K	0.04%	179

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WNY Asset Management's HQL Position: Q1 2026 in Review

WNY Asset Management opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2026: 14,710 shares worth $239K. The stake represents 0.02% of the portfolio and ranks #226 among its holdings. This is a return to the name: WNY Asset Management previously reported a position in HQL as recently as Q3 2025.

WNY Asset Management first reported a position in HQL in Q3 2024 and has held it in 6 quarters since. The position peaked at $399K in Q3 2025. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

WNY Asset Management held 14,710 shares of abrdn Life Sciences Investors worth $239K as of Q1 2026.
abrdn Life Sciences Investors was a new WNY Asset Management position in Q1 2026.
abrdn Life Sciences Investors made up 0.02% of WNY Asset Management's portfolio in Q1 2026, its #226 holding.
WNY Asset Management first reported a position in abrdn Life Sciences Investors in Q3 2024 and has held it in 6 quarters since.
WNY Asset Management's abrdn Life Sciences Investors position peaked at $399K in Q3 2025.
86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on WNY Asset Management's 13F filing for Q1 2026, filed 22 May 2026.